Newsroom
Sorted by: Latest
-
Upstart Publishes Monthly Origination Volumes
SAN MATEO, Calif.--(BUSINESS WIRE)--Upstart Publishes Monthly Origination Volumes...
-
Upstart Announces Leadership Evolution
SAN MATEO, Calif.--(BUSINESS WIRE)--Upstart Announces Leadership Evolution...
-
Upstart Announces Fourth Quarter and Full Year 2025 Results
SAN MATEO, Calif.--(BUSINESS WIRE)--Upstart Announces Fourth Quarter and Full Year 2025 Results...
-
Gilead Sciences Announces 3.8 Percent Increase in First Quarter 2026 Dividend
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 3.8% in the company’s quarterly cash dividend, beginning in the first quarter of 2026. The increase will result in a quarterly dividend of $0.82 per share of common stock. The dividend is payable on March 30, 2026, to stockholders of record at the close of business on March 13, 2026. Future dividends will be subject to Board approval. About...
-
Rambus Announces Departure of Chief Financial Officer
SAN JOSE, Calif.--(BUSINESS WIRE)--Rambus CFO Desmond Lynch to depart; John Allen named interim CFO; Q1 FY26 guidance reaffirmed...
-
Palantir and Airbus Extend Strategic Collaboration
DENVER--(BUSINESS WIRE)--Palantir Technologies (NASDAQ:PLTR) is proud to announce the extension of its collaboration with Airbus through a multi-year agreement, confirming a relationship that has driven innovation across the aerospace industry for over a decade. Under this renewed contract, Airbus will continue to rely on Palantir for Skywise, its civil aviation open data platform. The Skywise platform enhances aircraft and equipment designs and enables greater efficiency, safety and sustainabi...
-
CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced it will report financial results for the fourth quarter and full year 2025 after market close on Tuesday, February 24, 2026. The Company will host a webcast and conference call that day at 1:30...
-
Health Gorilla Publishes Engagement Summary Demonstrating Transparency, Integrity, and an Effective Governance Process
CORAL GABLES, Fla.--(BUSINESS WIRE)--Health Gorilla today published a documented summary of events detailing the rapid actions it first took months ago (and continues to take) in response to concerns raised by Epic regarding certain network participants’ access patterns. The summary reflects immediate action and sustained, good‑faith attempts to collaborate with Epic, recognized framework operators, and provider clinical stakeholders. These are objective facts Epic did not share in its recent l...
-
Gilead Sciences Announces Fourth Quarter and Full Year 2025 Financial Results
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2025. “Our fourth quarter and full-year results close out a very strong year for Gilead overall, including the successful U.S. launch of Yeztugo, the world’s first twice-yearly HIV prevention therapy, and continued growth for Biktarvy and Descovy,” said Daniel O’Day, Gilead’s Chairman and Chief Executive Officer. “In 2026, our potential new la...
-
Advanced Energy Reports Fourth Quarter and Full Year 2025 Results
DENVER--(BUSINESS WIRE)--Advanced Energy Industries, Inc. (Nasdaq: AEIS), a global leader in highly engineered, precision power conversion, measurement, and control solutions, announced financial results for the fourth quarter and year ended December 31, 2025. “Fourth quarter results exceeded our guidance, primarily driven by increased demand in the semiconductor market,” said Steve Kelley, president and CEO of Advanced Energy. “In 2025, we delivered strong revenue growth and meaningfully impro...